hs-cTnT, a specific and sensitive biomarker of myocardial injury, strongly correlates with the presence of subclinical CHD or other cardiac structural and functional abnormalities such as AF, left ventricular hypertrophy, and heart failure, all of which lead to adverse cardiovascular outcomes.32 Here, TNNT2 is linked to heart failure.